PUBLISHER: The Business Research Company | PRODUCT CODE: 1760686
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760686
Pharma grade calcium sulphate is a highly purified form of calcium sulphate (CaSO4) that has been specially processed and tested to meet rigorous pharmaceutical standards for use in medicines and healthcare applications. It is commonly used as a diluent or excipient in tablet and capsule formulations because of its high purity, controlled particle size, and non-toxic properties.
The primary types of pharma grade calcium sulphate include calcium sulphate dihydrate (CaSO4*2H2O), calcium sulphate hemihydrate, and calcium sulphate anhydrite. Calcium sulphate dihydrate serves as a pharmaceutical-grade excipient, acting as a binder, carrier, and controlled-release agent in drug formulations. Pharma-grade calcium sulphate has various applications, including use as pharmaceutical excipients, binders in tablets, calcium supplements, and diagnostic agents. It is distributed through several channels such as direct distribution, online sales, wholesale distribution, and retail outlets.
The pharma grade calcium sulphate market research report is one of a series of new reports from The Business Research Company that provides pharma grade calcium sulphate market statistics, including pharma grade calcium sulphate industry global market size, regional shares, competitors with a pharma grade calcium sulphate market share, pharma grade calcium sulphate market segments, market trends, and opportunities, and any further data you may need to thrive in the pharma grade calcium sulphate industry. This pharma grade calcium sulphate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharma grade calcium sulphate market size has grown strongly in recent years. It will grow from $0.89 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth observed in the historical period can be linked to the rising demand for pharmaceutical applications, increased use in medical treatments and surgeries, greater awareness of bone health, advancements in drug delivery systems, and a higher incidence of bone-related diseases.
The pharma grade calcium sulphate market size is expected to see strong growth in the next few years. It will grow to $1.36 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth anticipated in the forecast period is driven by factors such as the expanding aging population, the rise in bone and joint disorders, increased healthcare spending in emerging economies, greater use of calcium sulfate in regenerative medicine, and the expansion of the pharmaceutical industry. Key trends for the forecast period include a shift towards organic and natural sources of calcium sulfate, advancements in calcium sulfate synthesis techniques, a focus on sustainability and eco-friendly manufacturing, developments in controlled-release drug delivery systems, and innovations in drug formulations.
The growing demand for pharmaceuticals is expected to drive the expansion of the pharma grade calcium sulphate market. Pharmaceuticals are drugs developed for diagnosing, treating, or preventing diseases in both humans and animals. The demand for pharmaceuticals is largely driven by the increasing prevalence of chronic diseases, with more people needing long-term medications to manage conditions such as diabetes, heart disease, and cancer. Pharma grade calcium sulphate improves pharmaceutical formulations by acting as a high-purity excipient, ensuring consistent tablet hardness, stability, and controlled release of active ingredients. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations reported that North America accounted for 52.3% of global pharmaceutical sales in 2022, while Europe represented 22.4%. As a result, the rising demand for pharmaceuticals is contributing to the growth of the pharma grade calcium sulphate market.
Companies in the pharma grade calcium sulphate market are focusing on product development using synthetic medical-grade bassanite to improve the purity and consistency of calcium sulphate. Synthetic medical-grade bassanite, a high-purity form of calcium sulphate (CaSO4*0.5H2O), offers a reliable, contaminant-free source that meets strict regulatory standards for use in medical and pharmaceutical applications. For instance, in February 2025, the Sree Chitra Tirunal Institute for Medical Sciences & Technology in India launched Caspro & Bonyx, drug-eluting bone graft products made with synthetic medical-grade bassanite. These products are designed for advanced orthopedic applications and ensure high purity, biocompatibility, and controlled drug delivery. Caspro is a self-setting, mouldable bone cement used for bone defects, while Bonyx consists of osteoconductive bioceramic beads that can be loaded with antibiotics for sustained drug release. These products represent a significant advancement in localized therapy for bone infections and regeneration, showcasing how pharma-grade calcium sulfate can be applied in next-generation biomedical solutions.
In July 2024, Sudeep Pharma Pvt. Ltd., an India-based pharmaceutical company, acquired a 50% stake in JRS Pharma GmbH + Co. KG for an undisclosed amount. This acquisition aims to strengthen Sudeep Pharma's leadership position, accelerate innovation, and expand into emerging pharmaceutical and nutraceutical markets. JRS Pharma GmbH + Co. KG, based in Germany, manufactures Compactrol, a pharmaceutical-grade calcium sulfate product.
Major players in the pharma grade calcium sulphate market are Thermo Fisher Scientific Inc., Honeywell International Inc., Merck KGaA, Solvay S.A., Avantor Inc., MP Biomedicals LLC, Spectrum Chemical Manufacturing Corp., Anhui Sunhere Pharmaceutical Excipients, SRL Chemical, GFS Chemicals Inc., American Elements, Loba Chemie Pvt. Ltd., Annexe Chem, Noah Technologies Corporation, Junsei Chemical Co. Ltd, Nikunj Chemicals, Shiva Inorganics, Huzhou Zhanwang Pharmaceutical Co. Ltd., China Shuanghua Gypsum, Jingmen City Leixin Gypsum.
North America was the largest region in the pharma grade calcium sulphate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharma grade calcium sulphate report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pharma grade calcium sulphate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pharma grade calcium sulphate market consists of sales of USP-grade calcium sulfate dihydrate, anhydrous calcium sulfate, calcium sulfate hemihydrate (medical grade plaster of paris), injectable calcium sulfate pellets, and food or nutraceutical grade calcium sulfate. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharma Grade Calcium Sulphate Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pharma grade calcium sulphate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pharma grade calcium sulphate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma grade calcium sulphate market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.